Nosocomial pneumonia - are economical considerations important?
Ruef
C
C
D000284:Administration, Oral; D001372:Aza Compounds / Q000008:administration & dosage; D002443:Ceftriaxone / Q000008:administration & dosage; D002444:Cefuroxime / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000191:economics; D003428:Cross Infection / Q000188:drug therapy* / Q000191:economics*; D024841:Fluoroquinolones; D006801:Humans; D000077266:Moxifloxacin; D011014:Pneumonia / Q000188:drug therapy* / Q000191:economics*; D011804:Quinolines / Q000008:administration & dosage
D001372:Aza Compounds; D024841:Fluoroquinolones; D011804:Quinolines; D002443:Ceftriaxone; D002444:Cefuroxime; D000077266:Moxifloxacin; C040738:cefuroxime axetil